All In Biotech

Free tool

FAERS Monitor: Dextrose 70% In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019893 or its brand name (Dextrose 70% In Plastic Container, Dextrose). Reports on generic versions are filed under their own applications.

Reports

13,927

Serious

12,868

92% of reports

Hospitalization

6,983

Death reported

2,115

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • myelosuppression1,929
  • off label use1,093
  • nausea1,045
  • drug ineffective974
  • vomiting968
  • acute kidney injury809
  • white blood cell count decreased756
  • pyrexia742
  • dyspnoea694
  • sepsis588
  • abdominal pain544
  • hypotension535
  • neutrophil count decreased534
  • condition aggravated510
  • diarrhoea487

Reports by year received

View as table
YearReports
200453
200536
200649
200740
200864
200983
2010117
2011145
2012148
2013128
2014396
2015201
2016313
2017284
2018381
2019488
2020611
2021965
20221,714
20232,042
20241,959
20251,991
20261,717

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,232 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
myelosuppressionSignal1,92985.481.8152,472
neutrophil count decreasedSignal53420.018.49,531
white blood cell count decreasedSignal75610.69.96,551
acute kidney injurySignal8098.07.54,975
sepsisSignal5888.07.43,594
hypotensionSignal5354.03.71,227
abdominal painSignal5443.53.3996
pyrexiaSignal7423.23.01,166
vomitingSignal9683.12.91,416
condition aggravatedSignal5102.52.3479
nausea1,0452.01.9537
off label use1,0931.91.8473
dyspnoea6941.91.7279
diarrhoea4871.11.08
drug ineffective9741.11.112

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.